The Japanese Biochemical Society

[3P-359] Development of monoclonal antibodies against a cancer stem cell marker CD133

Junko Takei1,2, Mika Kaneko1, Shinji Yamada1, Tomokazu Ohishi3, Manabu Kawada3, Hiroyuki Harada2, Yukinari Kato1,4 (1.Department of Antibody Drug Development, Tohoku University Graduate School o f Medicine, 2.Department of Oral and Maxillofacial Surgery, Graduate School of Medical and Dental science, Tokyo Medical and Dental University, 3.Institute of Microbial Chemistry (BIKAKEN), Numazu, Microbial Chemistry Research Foundation, 4.New Industry Creation Hatchery Center, Tohoku University)

The 92nd Annual Meeting of JBS